Sanofi share price logo

Sanofi

NASDAQ: SNY

Large Cap

$40.07

-0.16

(-0.40%)

as on

Sanofi Stock Performance

as on October 10, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $39.92
    $40.30
    downward going graph

    0.37%

    Downside

    0.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $39.18
    $52.68
    downward going graph

    2.22%

    Downside

    31.47%

    Upside

    downward going graph

Sanofi share price movements today

Previous Close
$40.23
Open
$40.17
Volume
2.2M
Market Cap
$94.9B
Dividend Yield
6.02%
Day's Low - High
$39.92 - $40.30
52 Week Low - High
$39.18 - $52.68

Sanofi Historical Returns

1 Month Return
-6.11 %
3 Month Return
-8.36 %
1 Year Return
-17.6 %
3 Year Return
-25.57 %
5 Year Return
-17.91 %

Sanofi Stock Fundamentals & Key Indicators

Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$94.9B

EPS (TTM)

0.48

Dividend Yield

6.02%

Quarterly Earnings Growth YOY

-0.91%

PE Ratio (TTM)

21.96

Industry PE ratio

-19.23

PEG Ratio

-0.39

EBITDA

14.8B

Revenue (TTM)

48.9B

Profit Margin

72.77%

Return On Equity TTM

5.52%

Sanofi vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$94.9B-17.91%21.9672.77%6.02%
StrongBuy$1.1T399.96%39.7783.40%0.56%
StrongBuy$471.3B145.03%76.4571.48%2.52%
StrongBuy$614.0B59.37%29.8867.91%2.04%
Buy$350.2B76.58%113.3375.38%2.38%

Stock Returns calculator for Sanofi Stock including INR - Dollar returns

The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sanofi investment value today

Current value as on today

₹89,341

Returns

-₹10,659

(-10.66%)

Returns from Sanofi Stock

-₹17,923 (-17.92%)

Dollar Impact

₹7,264 (+7.26%)

Analyst Recommendation on Sanofi Stock

Based on 2 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'HOLD' rating for Sanofi. Average target price of $53.61

Sanofi Share Price Target

Get share price movements and forecasts by analysts on Sanofi.

What analysts predicted

25.26%UPSIDE

Target Price

$53.61

Current Price

$40.07

Analyzed by

2 Analysts

High

$57

Target

$53.61

Low

$57

Sanofi target price $53.61, a slight upside of 25.26% compared to current price of $40.07. According to 2 analysts rating.

Indian Investors' Interest in Sanofi Stock

Search interest for Sanofi Stock has increased by 48% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:48% versus previous 30 day period

Sanofi Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
12,201
9,726
11,380
7,631
10,606
10,735
13,170
12,205
11,244
12,300
Gross Profit
8,153
6,757
7,970
5,360
7,717
7,743
9,758
8,575
8,106
9,283
Operating Income
342
1,236
1,595
573
2,233
1,474
3,623
-1,038
2,269
2,384
EBITDA
2,823
1,867
2,781
2,579
2,770
3,269
4,198
3,823
2,716
4,037
Interest Expense
293
247
304
302
213
201
227
-100
178
287
Depreciation
2,973
484
1,254
2,225
399
1,758
461
1,972
535
2,913
Income Before Tax
-249
1,093
1,416
451
2,200
1,467
3,508
-1,155
2,014
828
Income Tax Expense
309
104
299
4
481
230
680
-348
420
451
Net Income
-555
1,133
1,113
499
1,872
3,940
2,802
-801
1,614
343
Net Profit Margin
66.82%
69.47%
70.04%
70.24%
72.76%
72.13%
74.09%
70.26%
72.09%
75.47%

Sanofi Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
36,221
35,677
37,631
37,369
39,175
40,561
41,618
44,286
46,716
Gross Profit
24,608
24,242
25,652
25,210
26,920
28,679
28,990
31,081
33,667
Operating Income
5,804
4,676
3,051
14,113
8,126
10,162
6,960
7,252
9,597
EBITDA
9,637
9,179
10,662
17,526
11,538
13,510
11,390
11,033
12,479
Interest Expense
333
486
536
430
377
384
512
622
626
Depreciation
3,686
4,279
7,445
3,314
3,351
3,108
4,429
3,586
5,678
Income Before Tax
5,616
4,904
3,007
14,137
7,837
9,992
6,115
6,758
6,020
Income Tax Expense
1,722
481
121
1,807
1,558
1,909
1,017
1,204
1,043
Net Income
8,416
4,306
2,754
12,294
6,223
8,371
5,400
5,560
7,813
Net Profit Margin
67.94%
67.95%
68.17%
67.46%
68.72%
70.71%
69.66%
70.18%
72.07%

Sanofi Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
1,970
1,133
2,209
683
-
3,940
2,802
-801
1,614
343
Operating Cash Flow
6,695
-
1,536
-
2,093
-
3,750
3,445
1,683
5,416
Investing Cash Flow
-3,127
-
-3,688
-
-776
-
-9,043
-2,131
-2,278
-3,083
Financing Cash Flow
-2,838
-
96
-
-592
-
-1,148
-2,570
-1,527
-3,886
Change in Cash
717
-
-2,338
-
550
-
8,906
-1,249
-2,113
-1,415

Sanofi Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
8,434
4,306
1,857
12,314
6,223
7,970
5,062
5,496
5,574
Operating Cash Flow
7,379
5,547
7,744
7,449
10,522
10,526
10,258
9,081
12,132
Investing Cash Flow
639
-12,872
-1,058
3,588
-7,298
-2,075
-6,200
-4,407
-2,761
Financing Cash Flow
-7,902
3,934
-4,193
-6,485
-7,056
-5,821
-8,052
-5,763
-9,262
Change in Cash
42
-3,390
2,502
4,488
-3,817
2,638
-4,026
-1,269
970

Global Institutional Holdings in Sanofi

Check out the Institutions with significant holdings in Sanofi.

Funds
Holdings
John A. Gunn
1.16%
Dodge & Cox Funds
0.96%
Ken Fisher
0.44%
Charles Brandes
0.17%
AIM Sector Funds (Invesco Sector Funds)
0.17%

Sanofi News & Key Events

  • img

    Today's Timeline - 02 October

    Fri, 11:51 PM

    -

    Regeneron and Sanofi expand alliance, potentially worth $8 billion, adding four key immunology assets.

Insights on Sanofi

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Sanofi ADS has shown positive revenue growth over the last two quarters. Revenue increased from $11.24 billion to $12.3 billion, representing an average quarter-on-quarter growth of 8.6%.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SNY stock has moved up by 0.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 36.2% return, outperforming this stock by 61.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Merck & Co., Inc. has given 62.7% return, outperforming this stock by 80.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Sanofi ADS has experienced a significant decline in net profit over the last two quarters. It dropped from $1.61 billion to $342.99 million, averaging a decrease of 78.8% per quarter.

About Sanofi

Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. Within its Pharmaceutical segment, Sanofi delivers specialized therapies, including innovative human monoclonal antibodies, addressing complex conditions like multiple sclerosis, various neurological disorders, immunology and inflammatory diseases, oncology, rare diseases, and rare blood disorders. This segment also encompasses treatments for diabetes, cardiovascular health, and established prescription medications. Its Vaccine portfolio is extensive, offering essential immunizations such as pediatric vaccines for poliomyelitis, pertussis, and Hib, alongside influenza shots, adult boosters, meningitis vaccines, and solutions for travel and endemic diseases. The Consumer Healthcare division provides a broad spectrum of over-the-counter products, including remedies for allergies, coughs and colds, pain management, liver support, physical and mental wellness, probiotics, digestive health aids, and nutritional supplements. Additionally, it offers various personal care items like daily body lotions, anti-itch creams, moisturizing and soothing lotions, body and foot creams, and specialized powders for eczema. Sanofi maintains a robust development pipeline, with numerous pharmaceutical products and vaccines currently in various stages of research. The company actively pursues strategic alliances, exemplified by its collaboration with GlaxoSmithKline on a recombinant Covid-19 vaccine, a research partnership with Stanford University School of Medicine focused on advancing immunology and inflammation understanding, and a collaboration and license option agreement with Prellis Biologics, Inc. Founded in 1973 and headquartered in Paris, France, the company was formerly known as Sanofi-Aventis before officially changing its name to Sanofi in May 2011.
OrganisationSanofi
Headquarters46, avenue de la Grande ArmEe, Paris, IF, 75017, FR
IndustryDrug Manufacturers - General
CEOBelén Garijo López

Key Management of Sanofi

Name

Title

Mr. François-Xavier Roger

Executive VP & CFO

Dr. Michael Quigley Ph.D.

Chief Scientific Officer & Head of Research

Ms. Jamie Haney

Executive VP & General Counsel

Mr. Pierre Chancel

Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing

Ms. Belen Garijo Lopez M.D.

CEO & Director

Mr. Thomas Kudsk Larsen

Head of Investor Relations & General Medicines

Ms. Veronique Jaillet

Executive VP & Interim Chief People Officer

Fabrizio Gaudi

Head of Austrian, German & Swiss Operations

Mr. Erik Wallström

Head of Therapeutic Area - Neurology Development

Mr. Thomas Triomphe

Executive Vice President of Vaccines

FAQs

What is Sanofi share price today?

Sanofi share price today is $40.07 as on at the close of the market. Sanofi share today touched a day high of $40.30 and a low of $39.92.

What is the 52 week high and 52 week low for Sanofi share?

Sanofi share touched a 52 week high of $52.68 on and a 52 week low of $39.18 on . Sanofi stock price today i.e. is closed at $40.07,which is 23.94% down from its 52 week high and 2.27% up from its 52 week low.

What is Sanofi's market capitalisation today?

Sanofi market capitalisation is $0.09T as on .

How to invest in Sanofi Stock (SNY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sanofi on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Sanofi Stock (SNY) from India?

Indian investors can start investing in Sanofi (SNY) shares with as little as ₹96.730003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.30 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ). Based on Sanofi share’s latest price of $40.07 as on October 10, 2026 at 1:29 am IST, you will get 0.2496 shares of Sanofi. Learn more about fractional shares .

What are the returns that Sanofi has given to Indian investors in the last 5 years?

Sanofi stock has given -17.91% share price returns and 27.85% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?